Brain scan study hopes to unlock memory treatments for schizophrenia
NCT ID NCT04457310
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 32 times
Summary
This study looked at whether an experimental drug (CVL-562) can change brain activity related to working memory in people with early schizophrenia. About 112 participants completed memory tasks while having their brains scanned. The goal was to find brain markers that could help develop better treatments for memory problems in schizophrenia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY COURSE SCHIZOPHRENIA SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University
New York, New York, 10032, United States
-
Stony Brook University
Stony Brook, New York, 11794, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Yale University
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.